Scarica l'app Stockscreener
2.08
0.73%
0.02
Precedente Chiudi:
$2.06
Aprire:
$2.02
Volume 24 ore:
28,057
Relative Volume:
0.07
Capitalizzazione di mercato:
$196.67M
Reddito:
$72.76M
Utile/perdita netta:
$35.34M
Rapporto P/E:
5.6323
EPS:
0.3693
Flusso di cassa netto:
$-62.91M
1 W Prestazione:
-1.66%
1M Prestazione:
+15.92%
6M Prestazione:
+50.36%
1 anno Prestazione:
+35.62%
Intervallo 1D:
$2.02
$2.08
Intervallo di 1 settimana:
$2.02
$2.165
Portata 52W:
$1.13
$2.38
Compugen Ltd Stock (CGEN) Company Profile
Compare CGEN vs VRTX, REGN, ALNY, ARGX, INSM
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CGEN
Compugen Ltd
|
2.08 | 194.78M | 72.76M | 35.34M | -62.91M | 0.3693 |
VRTX
Vertex Pharmaceuticals Inc
|
452.38 | 115.58B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
754.66 | 79.23B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
329.83 | 43.59B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
687.12 | 43.26B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
147.06 | 31.97B | 606.42M | -1.28B | -997.58M | -6.403 |
Compugen Ltd Stock (CGEN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-07 | Iniziato | H.C. Wainwright | Buy |
| 2025-01-13 | Iniziato | Oppenheimer | Outperform |
| 2022-08-05 | Downgrade | Jefferies | Buy → Hold |
| 2020-05-26 | Ripresa | JMP Securities | Mkt Outperform |
| 2020-05-13 | Iniziato | Stifel | Buy |
| 2020-05-07 | Iniziato | SVB Leerink | Outperform |
| 2020-04-22 | Iniziato | ROTH Capital | Buy |
| 2020-03-24 | Iniziato | SunTrust | Buy |
| 2020-01-16 | Iniziato | Cantor Fitzgerald | Overweight |
| 2018-03-29 | Iniziato | Oppenheimer | Outperform |
| 2016-02-01 | Ripresa | Oppenheimer | Outperform |
| 2015-10-15 | Iniziato | FBR Capital | Outperform |
| 2015-04-23 | Ripresa | Jefferies | Buy |
| 2015-04-21 | Iniziato | Oppenheimer | Outperform |
| 2014-02-07 | Iniziato | MLV & Co | Buy |
| 2009-12-28 | Reiterato | Cantor Fitzgerald | Buy |
| 2009-07-29 | Iniziato | Cantor Fitzgerald | Buy |
Mostra tutto
Compugen Ltd Borsa (CGEN) Ultime notizie
RSI Check: Does Compugen Ltd meet Warren Buffetts criteria2026 Gainers & Verified Swing Trading Watchlist - baoquankhu1.vn
If You Invested $1,000 in Compugen (CGEN) - Stock Titan
Aug Highlights: Is Compugen Ltd stock forming a triangle pattern2026 Performance Recap & Real-Time Volume Surge Alerts - baoquankhu1.vn
Retail Trends: Will Compugen Ltd outperform the market in YEARWeekly Gains Summary & Real-Time Volume Surge Alerts - baoquankhu1.vn
Compugen Ltd. (NASDAQ:CGEN) Q4 2025 earnings call transcript - MSN
Compugen shares jump nearly 5% after strong Q4 earnings beat - MSN
Compugen (CGEN) director discloses initial share and option holdings - Stock Titan
CGEN (COMPUGEN LTD) CFO David Silberman discloses initial share and option holdings - Stock Titan
Compugen (CGEN) director discloses initial shares, RSUs and option grants - Stock Titan
Compugen (CGEN) director Eran Perry details shares, RSUs and options - Stock Titan
Compugen (CGEN) CEO Ophir Eran details share and long-dated option holdings - Stock Titan
Compugen (CGEN) CMO Michelle Mahler details option and RSU holdings - Stock Titan
[Form 3] COMPUGEN LTD Initial Statement of Beneficial Ownership - Stock Titan
Compugen (CGEN) director Mathias Hukkelhoven details initial equity holdings - Stock Titan
Compugen (CGEN) director Holcomb reports shares, options and RSUs - Stock Titan
Halevy Gilead discloses initial Compugen (CGEN) share and option holdings - Stock Titan
Compugen (CGEN) COO discloses 400,000 share options in Form 3 - Stock Titan
Compugen (CGEN) director Anat Cohen-Dayag reports initial share and option holdings - Stock Titan
Compugen (CGEN) SVP reports RSU and option stakes in Form 3 filing - Stock Titan
Sectors Review: What is the cash position of Compugen Ltd2026 Price Momentum & Safe Capital Preservation Plans - baoquankhu1.vn
Movement Recap: Whats the analyst consensus on Compugen LtdWeekly Risk Report & AI Forecasted Stock Moves - baoquankhu1.vn
Compugen Ltd. (CGEN) reports Q4 revenue of $67.3 million vs. $1.5 million last year - MSN
Institution Moves: How is Compugen Ltd managing supply chain issuesQuarterly Earnings Summary & Weekly Chart Analysis and Guides - baoquankhu1.vn
Compugen Ltd. (CGEN) Reports Q4 Revenue of $67.3 Million vs. $1.5 Million Last Year - Insider Monkey
Compugen (CGEN) Q4 2025 Earnings Call Transcript - AOL.com
Compugen at Leerink Global Healthcare Conference: Strategic Insights By Investing.com - Investing.com Australia
Compugen at Leerink Global Healthcare Conference: Strategic Insights - Investing.com South Africa
Short Squeeze: Is Compugen Ltd stock forming a triangle pattern2026 PreEarnings & Consistent Growth Stock Picks - baoquankhu1.vn
CGEN Earnings History & Surprises | EPS & Revenue Results | COMPUGEN LTD (NASDAQ:CGEN) - ChartMill
Q1 Earnings Estimate for Compugen Issued By HC Wainwright - Defense World
BillionToOne Stock at $89: Why a New $19.1 Million Position Could Matter Now - AOL.com
3 Reasons Exelixis Stock Could Deliver Market‑Beating Returns Over the Next Decade - AOL.com
Compugen Q4 Earnings Call Highlights - Defense World
Compugen Ltd (CGEN) Q4 2025 Earnings Call Highlights: Strong Rev - GuruFocus
Why Tempus AI Stock Is Up Today — And What to Watch Before Next Week’s Earnings - AOL.com
Cumberland (CPIX) Q4 2025 Earnings Call Transcript - AOL.com
Compugen Ltd. (NASDAQ:CGEN) Q4 2025 Earnings Call Transcript - Insider Monkey
Compugen (CGEN) Quarterly Loss Near US$7 Million Tests Bullish Profitability Narrative - simplywall.st
From Sizable Stake to Zero: The Likely Reason Why Agios Shares Lost a $94 Million Backer - AOL.com
Investment Advisor Bets Big on CMPX Stock, Adds 2.5 Million Shares, According to Latest SEC Filing - AOL.com
Compugen earnings beat by $0.68, revenue topped estimates - Investing.com South Africa
Chegg Earnings: Big Quarter Sends Shares Higher - AOL.com
Compugen: Non-Dilutive Funding For Rilvegostomig Obtained And GS-0321 Advancement (CGEN) - Seeking Alpha
Compugen Ltd. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 - marketscreener.com
Compugen Q4 2025 Earnings Call Transcript - MarketBeat
Compugen Ltd. Q4 2025 Earnings Call Summary - Yahoo Finance
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
What Smart Money Loves About Lilly - AOL.com
Viridian Therapeutics Stock Up 75%, but One Fund Just Sold Off Its $69 Million Stake - AOL.com
Earnings call transcript: Compugen Q4 2025 sees earnings beat, stock surges - Investing.com
CGEN: 2025 saw a cash runway extension, profitability, and global clinical trial progress - TradingView
Compugen Ltd Azioni (CGEN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.99%
3.03%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):